For the Inventor, By the Inventor

Enter assignee name

Houston, TX, United States of America

Tanox Biosystems, Inc.

USPTO Granted Patents = 44

Forward Citations = 1,247

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Tse W Chang (26 out of 32 patents)

Tse-wen Chang (10 out of 11 patents)

Nancy T Chang (7 out of 22 patents)

4. Cecily R Sun (6 out of 9 patents)

5. Bill N Sun (6 out of 9 patents)

6. Michael S Fung (6 out of 9 patents)

7. Liming Yu (5 out of 6 patents)

8. Young Woo Kim (5 out of 6 patents)

9. Jose William Saldanha (3 out of 48 patents)

10. Norman Hardman (3 out of 8 patents)

11. Frank Kolbinger (3 out of 3 patents)

12. Bill Nai-Chau Sun (2 out of 2 patents)

13. Cecily Rou-Yun Sun (2 out of 2 patents)

14. Jean deVilliers (1 out of 1 patent)

15. Wayne Gordon (1 out of 1 patent)

Core Competencies:

Monoclonal Antibodies

Immunoconjugates

HIV-1 Neutralization

IgE Antibodies

B Lymphocytes

Chimeric Antibodies

Peptide Antigens

Extracellular Immunoglobulin

Allergen-Specific Antibodies

Antibody Production

Immunoassay Devices

Antigenic Epitopes

44 patents: Sort by Forward Citations

1. 6072035 - Reshaped monoclonal antibodies against an immunoglobulin isotype (2000-06-06),

2. 6066718 - Reshaped monoclonal antibodies against an immunoglobulin isotype (2000-05-23),

3. 5958708 - Reshaped monoclonal antibodies against an immunoglobulin isotype (1999-09-28),

4. 5872222 - Conjugates of polymers and antibodies specific for T lymphocytes, and (1999-02-16),

5. 5866129 - Method of producing an antibody with a peptide corresponding to (1999-02-02),

6. 5834599 - Immunoconjugates which neutralize HIV-1 infection (1998-11-10),

7. 5739306 - gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1998-04-14),

8. 5728814 - GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1998-03-17),

9. 5723125 - Hybrid with interferon-alpha and an immunoglobulin Fc linked through a (1998-03-03),

10. 5691447 - GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1997-11-25),

11. 5690934 - Peptides relating to the extracellular membrane-bound segment of human (1997-11-25),

12. 5670626 - Allergen-specific human IgA monoclonal antibodies for mucosal (1997-09-23),

13. 5652333 - gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides (1997-07-29),

14. 5614611 - Humanized monoclonal antibodies binding to IgE-bearing B cells but not (1997-03-25),

15. 5543144 - Treating hypersensitivities with anti-IGE monoclonal antibodies which (1996-08-06),

Tanox Biosystems, Inc. is a biotechnology company specializing in the development and commercialization of therapeutic antibodies. With a mission to improve patient lives, Tanox focuses on discovering and advancing innovative biologic therapies for the treatment of various diseases. Leveraging its expertise in antibody technologies, the company aims to address unmet medical needs and create novel solutions in the field of targeted therapeutics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

44 Patents

#130 in Houston, TX

#442 in Texas

#7,676 in US

#15,298 in the World

Houston, TX, United States of America

Tanox Biosystems, Inc.

Forward Citations = 1,247

16 inventors:

Tse W Chang (26 out of 32 patents)

Tse-wen Chang (10 out of 11 patents)

Nancy T Chang (7 out of 22 patents)

4. Cecily R Sun (6 out of 9 patents)

5. Bill N Sun (6 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…